Zhang Jiajun, Li Xiaoxing, Xu Feng, Chen Yuguo, Li Chuanbao
Department of Emergency Medicine and Chest Pain Center, Cheeloo College of Medicine, Qilu Hospital of Shandong University, Jinan, China.
Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Qilu Hospital of Shandong University, Jinan, China.
Front Cardiovasc Med. 2022 May 26;9:884911. doi: 10.3389/fcvm.2022.884911. eCollection 2022.
Studies on the association of Sievers bicuspid aortic valve (BAV) morphology with conduction disorders after transcatheter aortic valve replacement (TAVR) have not reached consensus.
We here performed a pooled-analysis to explore whether Sievers type 1 BAV morphology increased the risk of post-TAVR conduction abnormalities and permanent pacemaker implantation (PPI) compared to type 0. Systematic literature searches through EMBASE, Medline, and Cochrane databases were concluded on 1 December 2021. The primary endpoint was post-TAVR new PPI and pooled as risk ratios (RRs) and 95% confidence intervals (CIs). Conduction abnormalities as the secondary endpoint were the composites of post-TAVR PPI and/or new-onset high-degree of atrial-ventricle node block and left-bundle branch block. Studies that reported incidence of outcomes of interest in both type 1 and type 0 BAV morphology who underwent TAVR for aortic stenosis were included.
Finally, nine studies were included. Baseline characteristics were generally comparable, but type 1 population was older with a higher surgical risk score compared to type 0 BAV morphology. In the pooled-analysis type 1 BAV had significantly higher risk of post-TAVR new-onset conduction abnormalities ( = 1.68, 95% 1.09-2.60, = 0.0195) and new PPI ( = 1.97, 95% 1.29-2.99, = 0.0016) compared to type 0. Random-effects univariate meta-regression indicated that no significant association between baseline characteristics and PPI.
Sievers type 1 BAV morphology was associated with increased risk of post-TAVR PPI and conduction abnormalities compared to type 0. Dedicated cohort is warranted to further validate our hypothesis.
关于经导管主动脉瓣置换术(TAVR)后,西弗斯二叶式主动脉瓣(BAV)形态与传导障碍之间关联的研究尚未达成共识。
我们在此进行了一项汇总分析,以探究与0型相比,西弗斯1型BAV形态是否会增加TAVR后传导异常和永久起搏器植入(PPI)的风险。通过EMBASE、Medline和Cochrane数据库进行的系统文献检索于2021年12月1日结束。主要终点是TAVR后新的PPI,并汇总为风险比(RRs)和95%置信区间(CIs)。作为次要终点的传导异常是TAVR后PPI和/或新发高度房室结阻滞及左束支传导阻滞的综合情况。纳入了那些报告了因主动脉瓣狭窄接受TAVR的1型和0型BAV形态患者中感兴趣结局发生率的研究。
最终纳入了9项研究。基线特征总体上具有可比性,但与0型BAV形态相比,1型人群年龄更大,手术风险评分更高。在汇总分析中,与0型相比,1型BAV在TAVR后发生新发传导异常(RR = 1.68,95% CI 1.09 - 2.60,P = 0.0195)和新PPI(RR = 1.97,95% CI 1.29 - 2.99,P = 0.0016)的风险显著更高。随机效应单变量meta回归表明基线特征与PPI之间无显著关联。
与0型相比,西弗斯1型BAV形态与TAVR后PPI和传导异常风险增加有关。需要专门的队列研究来进一步验证我们的假设。